Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Drug-resistant TB news

Show

From To
Early data indicates new regimen represents reprieve for patients with XDR TB

Data from an ongoing trial presented today indicates patients with extensively drug resistant tuberculosis for whom other treatments had failed, showed signs of full recovery from disease following a six-month regimen of two new tuberculosis drugs and one repurposed drug.

Published
31 October 2016
From
Science Speaks
Final data backs early findings, WHO recommendations, showing shorter MDR TB treatment course working better

Presenting results today of a nine month treatment regimen that led to an 82 percent cure rate among 1006 patients with multidrug-resistant tuberculosis, researchers called their findings a breakthrough that can support countries in adopting shorter, more effective and potentially less damaging treatment for TB that is resistant to more than one first line treatment.

Published
26 October 2016
From
Science Speaks
Access: MSF reports on use of the new tuberculosis drugs bedaquiline and delamanid

Access to the new tuberculosis (TB) drugs remains severely limited worldwide, but MSF hopes its experience can inform and encourage wider use, while needed clinical research continues.

Published
26 October 2016
From
Médecins Sans Frontières (MSF) International
Global pledge to stamp out drug-resistant infections

The 193 countries of the United Nations sign a landmark declaration to rid the world of drug-resistant infections or superbugs.

Published
21 September 2016
From
BBC Health
Without Success in India, We'll Never Control Drug-Resistant Tuberculosis Anywhere

Two newly released studies from India make the global fight against antibiotic resistance and drug-resistant tuberculosis (TB) feel even more daunting. India is critical to the control of TB and other antibiotic resistance, as it is both the largest consumer of antibiotics in the world and has the highest burden of TB, affecting 2.2 million of its people each year, a quarter of the world total.

Published
01 September 2016
From
Forbes
HIV is not a super-spreader of drug-resistant tuberculosis

While the human immunodeficiency virus (HIV) pandemic fuels tuberculosis (TB) outbreaks, it does not drive the development and transmission of multidrug-resistance in TB patients as previously suspected, according to a study published in eLife.

Published
09 August 2016
From
EurekAlert (press release)
Frequently asked questions about the implementation of the new WHO recommendation on the use of the shorter MDR-TB regimen

These FAQs address key points regarding the implementation of the WHO treatment guidelines for drug-resistant tuberculosis, 2016 update, in TB and TB/HIV programmes.

Published
15 June 2016
From
World Health Organization
The Worst Superbug? Tuberculosis

The ground-breaking publication of Lord Jim O'Neill's global Review on Antimicrobial Resistance (AMR) is the wake-up call the world desperately needs. Have no doubts: the 'superbugs' that develop antimicrobial resistance are a threat of immense proportions and have a potential impact of 10 million deaths a year by 2050 as antibiotic efficacy dwindles.

Published
20 May 2016
From
Huffington Post UK
Rapid diagnostic test and shorter, cheaper treatment signal new hope for multidrug-resistant tuberculosis patients

New WHO recommendations aim to speed up detection and improve treatment outcomes for multidrug resistant tuberculosis (MDR-TB) through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

Published
12 May 2016
From
World Health Organization
STREAM clinical study first to include bedaquiline to test shortened treatment regimens for multidrug-resistant III in Phase III trial

Stage 2 of the trial aims to reduce MDR-TB treatment from 24 months to 6 or 9 months.

Published
18 April 2016
From
International Union Against Tuberculosis and Lung Disease
← First12345...18Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.